Warum Bitcoin als Wertspeicher in keinem diversifizierten Portfolio fehlen sollte. Jetzt lesen -w-
25.09.2017 22:18:00

Project Update: Farellon Copper-Gold Vein System, Chile

 APN: TSX-V

EDMONTON, Sept. 25, 2017 /CNW/ - Altiplano Minerals Ltd. (TSX-V: APN) (OTCQB:ALTPF) (FWB: 9AJ1) ("APN" or the "Company") is pleased to provide an update at the Company's Comet Joint Venture, the Farellon Copper-Gold Project, Tambillos, Chile.

Figure 1 - Farellon Vein. Inclined Long-Section (CNW Group/Altiplano Minerals)

To date, the CJV has advanced the 3.5 m high by 3.5 m wide adit approximately 360 m at a 15% decline from surface. In addition, the CJV has installed a vent raise, escape way up to the Alejandro tunnel, completed fortifying the tunnel entrance with rock bolts, wire mesh and shotcrete for safety, and the completion of 18 additional diamond drill holes from the decline.

The CJV has now intersected the Farellon Cu-Au vein system over 255 m in strike length and it remains open (Figure 1). Along the 255m length the vein averages approximately 1.5 m in width. The average grade of the 1.5 m wide zone is approximately 1.5% Copper ranging between 1 and 2.56%. The best intersects thus far are in hole 7, grading 2.28% Cu over 2.9m and hole 19 grading 2.56% Cu over 1.56m. Gold assays are still pending.

Pattern drilling will continue along strike from 320-400m down the decline into October and then infill around the higher- grade intercepts will be conducted for resource estimation and planning. 

Altiplano Minerals Ltd. (APN: TSXV) is a mineral exploration company focused on evaluating and acquiring projects with significant potential for advancement from discovery through to production, in Canada and abroad.  Management has a substantial record of success in capitalizing opportunity, overcoming challenges and building shareholder value.  Additional information concerning Altiplano can be found on its website at www.altiplanominerals.com

ON BEHALF OF THE BOARD

/s/ "John Williamson"
President and CEO

Tel: (780) 437-6624

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the (TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

This release includes certain statements that may be deemed "forward-looking statements". All statements in this release, other than statements of historical facts, that address exploration drilling, exploitation activities and events or developments that the Company expects are forward-looking statements. Although the Company believes the expectations expressed in such forward-looking statements are based on reasonable assumptions, such statements are not guarantees of future performance and actual results or developments may differ materially from those in the forward-looking statements. Factors that could cause actual results to differ materially from those in forward-looking statements include market prices, exploitation and exploration successes, continuity of mineralization, uncertainties related to the ability to obtain necessary permits, licenses and title and delays due to third party opposition, changes in government policies regarding mining and natural resource exploration and exploitation, and continued availability of capital and financing, and general economic, market or business conditions. Investors are cautioned that any such statements are not guarantees of future performance and actual results or developments may differ materially from those projected in the forward-looking statements. For more information on the Company, investors should review the Company's continuous disclosure filings that are available at www.sedar.com.

SOURCE Altiplano Minerals

Analysen zu ResMed Inc.mehr Analysen

Eintrag hinzufügen
Hinweis: Sie möchten dieses Wertpapier günstig handeln? Sparen Sie sich unnötige Gebühren! Bei finanzen.net Brokerage handeln Sie Ihre Wertpapiere für nur 5 Euro Orderprovision* pro Trade? Hier informieren!
Es ist ein Fehler aufgetreten!

Aktien in diesem Artikel

ResMed Inc. 231,90 -0,98% ResMed Inc.
Royal Bank of Canada 118,26 -0,08% Royal Bank of Canada